{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:31:42Z","timestamp":1792171902780,"version":"4.4.0"},"reference-count":256,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M743104"],"award-info":[{"award-number":["2023M743104"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZC20232365"],"award-info":[{"award-number":["GZC20232365"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22075247"],"award-info":[{"award-number":["22075247"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32225029"],"award-info":[{"award-number":["32225029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioactmat.2025.02.043","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T09:17:42Z","timestamp":1741598262000},"page":"218-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Advances in locally administered nucleic acid therapeutics"],"prefix":"10.1016","volume":"49","author":[{"given":"Jie","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8758-3812","authenticated-orcid":false,"given":"Yue","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4106-0344","authenticated-orcid":false,"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanrong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2025.02.043_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s42003-024-06121-9","article-title":"Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs","volume":"7","author":"Baylot","year":"2024","journal-title":"Commun. Biol."},{"issue":"6","key":"10.1016\/j.bioactmat.2025.02.043_bib2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.02.043_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","article-title":"Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants","volume":"18","author":"Makarova","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: considerations and future directions","volume":"23","author":"Tang","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101006","article-title":"Strategies and materials of \"SMART\" non-viral vectors: overcoming the barriers for brain gene therapy","volume":"35","author":"Li","year":"2020","journal-title":"Nano Today"},{"issue":"12","key":"10.1016\/j.bioactmat.2025.02.043_bib7","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.02.043_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Therapeut."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.02.043_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41587-023-02105-y","article-title":"RNA interference in the era of nucleic acid therapeutics","volume":"42","author":"Jadhav","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib10","article-title":"Enhancing siRNA efficacy in vivo with extended nucleic acid backbones","author":"Yamada","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.bioactmat.2025.02.043_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: considerations and future directions","volume":"23","author":"Tang","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s11095-013-0971-1","article-title":"Delivery systems and local administration routes for therapeutic siRNA","volume":"30","author":"Vicentini","year":"2013","journal-title":"Pharm. Res-Dordr."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.abb.2016.03.005","article-title":"Transfer RNA: from pioneering crystallographic studies to contemporary tRNA biology","volume":"602","author":"Fern\u00e1ndez-Mill\u00e1n","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"issue":"46","key":"10.1016\/j.bioactmat.2025.02.043_bib14","doi-asserted-by":"crossref","first-page":"17337","DOI":"10.1073\/pnas.0607015103","article-title":"Small dsRNAs induce transcriptional activation in human cells","volume":"103","author":"Li","year":"2006","journal-title":"P. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-10-4310-9_1","article-title":"Small RNA-guided transcriptional gene activation (RNAa) in mammalian cells","volume":"983","author":"Li","year":"2017","journal-title":"RNA Activation"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.02.043_bib16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1073\/pnas.75.1.280","article-title":"Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide","volume":"75","author":"Zamecnik","year":"1978","journal-title":"P. Natl. Acad. Sci. USA."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib17","first-page":"245","article-title":"Fomivirsen, drug","volume":"37","author":"Grillone","year":"2001","journal-title":"Today Off."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nn.4508","article-title":"Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy","volume":"20","author":"Corey","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.bioactmat.2025.02.043_bib19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40265-023-01904-6","article-title":"Tofersen: first approval","volume":"83","author":"Blair","year":"2023","journal-title":"Drugs"},{"issue":"32","key":"10.1016\/j.bioactmat.2025.02.043_bib20","doi-asserted-by":"crossref","first-page":"16618","DOI":"10.1039\/c3ra47841f","article-title":"Nucleic acid therapeutics: basic concepts and recent developments","volume":"4","author":"Sharma","year":"2014","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib21","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","article-title":"Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs","volume":"46","author":"Shen","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.bioactmat.2025.02.043_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nbt.4136","article-title":"Reversal of siRNA - mediated gene silencing","volume":"36","author":"Zlatev","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.02.043_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bioactmat.2025.02.043_bib24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2012.08.014","article-title":"Single-stranded siRNAs activate RNAi in animals","volume":"150","author":"Lima","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bioactmat.2025.02.043_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/bjs.10790","article-title":"Role of micro-RNAs in breast cancer surgery","volume":"105","author":"McAnena","year":"2018","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.02.043_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0034-1397344","article-title":"Overview of microRNA biology","volume":"35","author":"Mohr","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41570-017-0076","article-title":"Analysis of aptamer discovery and technology","volume":"1","author":"Dunn","year":"2017","journal-title":"Nat. Rev. Chem"},{"issue":"7","key":"10.1016\/j.bioactmat.2025.02.043_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4968","key":"10.1016\/j.bioactmat.2025.02.043_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Craig","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addr.2018.07.003","article-title":"Aptamers: uptake mechanisms and intracellular applications","volume":"134","author":"Yoon","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib31","first-page":"151","article-title":"Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases","volume":"1082","author":"Ng","year":"2006","journal-title":"Oligonucleotide Therapeutics"},{"issue":"17","key":"10.1016\/j.bioactmat.2025.02.043_bib32","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial","volume":"37","author":"Patel","year":"2023","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib33","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.apsb.2023.01.017","article-title":"Recent progress of aptamer\u2012drug conjugates in cancer therapy","volume":"13","author":"He","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.bioactmat.2025.02.043_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/gt.2008.183","article-title":"Progress and prospects: the design and production of plasmid vectors","volume":"16","author":"Gill","year":"2009","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.02.043_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40256-016-0210-3","article-title":"Results of an international postmarketing surveillance study of pl-VEGF165 safety and efficacy in 210 patients with peripheral arterial disease","volume":"17","author":"Deev","year":"2017","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib36","series-title":"Molecular and Biological Characterization of Messenger RNA, Cold Spring Harbor Symposia on Quantitative Biology","first-page":"111","author":"Gros","year":"1961"},{"issue":"13","key":"10.1016\/j.bioactmat.2025.02.043_bib37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cub.2015.05.032","article-title":"Who discovered messenger RNA?","volume":"25","author":"Cobb","year":"2015","journal-title":"Curr. Biol."},{"issue":"10","key":"10.1016\/j.bioactmat.2025.02.043_bib38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.cgt.7700961","article-title":"Phase I\/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA","volume":"13","author":"Kyte","year":"2006","journal-title":"Cancer Gene Ther."},{"issue":"7830","key":"10.1016\/j.bioactmat.2025.02.043_bib39","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101142","article-title":"Role of nanotechnology behind the success of mRNA vaccines for COVID-19","volume":"38","author":"Khurana","year":"2021","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.02.043_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","article-title":"Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity","volume":"34","author":"Fotin-Mleczek","year":"2011","journal-title":"J. Immunother."},{"issue":"10","key":"10.1016\/j.bioactmat.2025.02.043_bib42","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics - developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib43","article-title":"Branched chemically modified poly(A) tails enhance the translation capacity of mRNA","author":"Chen","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.omtn.2019.06.011","article-title":"Improving the repeatability and efficacy of intradermal electroporated self-replicating mRNA","volume":"17","author":"Huysmans","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"6","key":"10.1016\/j.bioactmat.2025.02.043_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1803","article-title":"Design principles and applications of synthetic self-replicating RNAs","volume":"14","author":"Wagner","year":"2023","journal-title":"Wires Rna"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib46","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2022.05.043","article-title":"Circular RNA: an emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines","volume":"348","author":"Liu","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib48","series-title":"Engineered Polynucleotides for Cell-type or Microenvironment-specific Expression, ModernaTX","author":"Jain","year":"2022"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib49","series-title":"Improved Nucleic Acid Sequence for Cell Type Specific Expression","author":"Thran","year":"2022"},{"issue":"6096","key":"10.1016\/j.bioactmat.2025.02.043_bib50","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"6121","key":"10.1016\/j.bioactmat.2025.02.043_bib51","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bioactmat.2025.02.043_bib52","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s41591-022-01906-z","article-title":"CRISPR\u2013Cas9-mediated gene editing of the BCL11A enhancer for pediatric \u03b20\/\u03b20 transfusion-dependent \u03b2-thalassemia","volume":"28","author":"Fu","year":"2022","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bioactmat.2025.02.043_bib53","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41580-020-00288-9","article-title":"Applications of CRISPR-Cas in agriculture and plant biotechnology","volume":"21","author":"Zhu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bioactmat.2025.02.043_bib54","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1039\/D1BM01658J","article-title":"Non-viral delivery of the CRISPR\/Cas system: DNA versus RNA versus RNP","volume":"10","author":"Lin","year":"2022","journal-title":"Biomater. Sci-Uk."},{"issue":"6213","key":"10.1016\/j.bioactmat.2025.02.043_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib56","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1039\/D0SC06973F","article-title":"CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules","volume":"12","author":"Feng","year":"2021","journal-title":"Chem. Sci."},{"issue":"12","key":"10.1016\/j.bioactmat.2025.02.043_bib57","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.tplants.2019.09.006","article-title":"CRISPR\/Cas system: recent advances and future prospects for genome editing","volume":"24","author":"Manghwar","year":"2019","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib58","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/s41467-018-05245-x","article-title":"Direct observation of DNA target searching and cleavage by CRISPR-Cas12a","volume":"9","author":"Jeon","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41421-019-0091-0","article-title":"Artificial sgRNAs engineered for genome editing with new Cas12b orthologs","volume":"5","author":"Teng","year":"2019","journal-title":"Cell Discov"},{"issue":"7675","key":"10.1016\/j.bioactmat.2025.02.043_bib60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nature24049","article-title":"RNA targeting with CRISPR-Cas13","volume":"550","author":"Abudayyeh","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib61","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.molcel.2016.12.023","article-title":"Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28","volume":"65","author":"Smargon","year":"2017","journal-title":"Mol. Cell"},{"issue":"6416","key":"10.1016\/j.bioactmat.2025.02.043_bib62","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.aav4294","article-title":"Programmed DNA destruction by miniature CRISPR-Cas14 enzymes","volume":"362","author":"Harrington","year":"2018","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bioactmat.2025.02.043_bib63","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.4049\/jimmunol.1402989","article-title":"Cholesterol modification of p40-specific small interfering RNA enables therapeutic targeting of dendritic cells","volume":"195","author":"Br\u00fcck","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib64","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s41467-024-45609-0","article-title":"Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy","volume":"15","author":"Hoogenboezem","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bioactmat.2025.02.043_bib65","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","article-title":"Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates","volume":"40","author":"Brown","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.bioactmat.2025.02.043_bib66","article-title":"Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzyme cleavable linker mediated effective intracellular delivery of siRNA","volume":"606","author":"Yu","year":"2021","journal-title":"Int. J. Pharmaceut."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.02.043_bib67","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/nar\/gky1232","article-title":"Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways","volume":"47","author":"Osborn","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.bioactmat.2025.02.043_bib68","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219523120","article-title":"Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection","volume":"120","author":"Hariharan","year":"2023","journal-title":"P. Natl. Acad. Sci. USA."},{"issue":"14","key":"10.1016\/j.bioactmat.2025.02.043_bib69","doi-asserted-by":"crossref","first-page":"13147","DOI":"10.1021\/acsnano.2c11904","article-title":"Insights into the structure of comirnaty Covid-19 vaccine: a theory on soft, partially bilayer-covered nanoparticles with hydrogen bond-stabilized mRNA-lipid complexes","volume":"17","author":"Szebeni","year":"2023","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.bioactmat.2025.02.043_bib79","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/pharmaceutics13091472","article-title":"mRNA-based nanomedicinal products to address corneal inflammation by interleukin-10 supplementation","volume":"13","author":"G\u00f3mez-Aguado","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib80","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejpb.2019.06.009","article-title":"Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model","volume":"142","author":"Jansen","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib81","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.omtn.2023.04.006","article-title":"Efficient transfected liposomes co-loaded with pNrf2 and pirfenidone improves safe delivery for enhanced pulmonary fibrosis reversion","volume":"32","author":"Chang","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib82","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.omtn.2023.02.031","article-title":"Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment","volume":"32","author":"Yan","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.bioactmat.2025.02.043_bib83","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.7150\/thno.48152","article-title":"Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis","volume":"11","author":"Pan","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib84","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/vaccines8040619","article-title":"A DNA vaccine encoding PfRH5 in cationic liposomes for dermal tattooing immunization","volume":"8","author":"Fotoran","year":"2020","journal-title":"Vaccines-Basel."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib76","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/EXP.20210008","article-title":"Membrane\u2010destabilizing ionizable lipid empowered imaging\u2010guided siRNA delivery and cancer treatment","volume":"1","author":"Guo","year":"2021","journal-title":"Exploration"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib85","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Realveolarization with inhalable mucus-penetratinglipid nanoparticles for the treatment of pulmonaryfibrosis in mice","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119736","article-title":"Ultrasound-activated particles as CRISPR\/Cas9 delivery system for androgenic alopecia therapy","volume":"232","author":"Ryu","year":"2020","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.bioactmat.2025.02.043_bib87","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1039\/D3TB00598D","article-title":"Mucin-targeting-aptamer functionalized liposomes for delivery of cyclosporin A for dry eye diseases","volume":"11","author":"Wong","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib88","article-title":"Double braking effects of nanomedicine on mitochondrial permeability transition pore for treating idiopathic pulmonary fibrosis","author":"Lu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib89","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41467-024-53914-x","article-title":"Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib91","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates","volume":"9","author":"Herrera-Barrera","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib92","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41467-023-42189-3","article-title":"Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina","volume":"14","author":"Gautam","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib93","article-title":"Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations","author":"Holubowicz","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2014.11.010","article-title":"Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior","volume":"41","author":"Li","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib74","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib94","first-page":"86","article-title":"Engineering LNPs with polysarcosine lipids for mRNA delivery","volume":"37","author":"Kang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Tar."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib71","article-title":"Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib73","series-title":"Investigating Potency and Efficacy of mRNA Lipid Nanoparticle Systems and Targeting Lymph Node","author":"Binici","year":"2024"},{"issue":"7","key":"10.1016\/j.bioactmat.2025.02.043_bib75","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib77","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/s41467-024-50093-7","article-title":"Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","volume":"15","author":"Su","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bioactmat.2025.02.043_bib78","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.xphs.2022.12.026","article-title":"Effect of cholesterol content of lipid composition in mRNA-LNPs on the protein expression in the injected site and liver after local administration in mice","volume":"112","author":"Kawaguchi","year":"2023","journal-title":"J. Pharm. Sci-Us."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib95","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1166\/jbn.2011.1313","article-title":"Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids","volume":"7","author":"Nimesh","year":"2011","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib96","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2021.01.014","article-title":"Polymeric delivery systems for nucleic acid therapeutics: approaching the clinic","volume":"331","author":"van den Berg","year":"2021","journal-title":"J. Contr. Release"},{"issue":"24","key":"10.1016\/j.bioactmat.2025.02.043_bib97","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1039\/D4PY00206G","article-title":"Rational design of polymer-based mRNA delivery systems for cancer treatment","volume":"15","author":"Wan","year":"2024","journal-title":"Polym. Chem-Uk"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib99","article-title":"Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment","volume":"6","author":"Aini","year":"2016","journal-title":"Sci. Rep-Uk"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.omtn.2019.06.016","article-title":"Enhancement of motor function recovery after spinal cord injury in mice by delivery of brain-derived neurotrophic factor mRNA","volume":"17","author":"Crowley","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.02.043_bib101","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/acsnano.1c08473","article-title":"Intranasal administration of self-oriented nanocarriers based on therapeutic exosomes for synergistic treatment of Parkinson's disease","volume":"16","author":"Peng","year":"2022","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.bioactmat.2025.02.043_bib98","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s13770-017-0059-9","article-title":"Local delivery of CTGF siRNA with poly(sorbitol-co-PEI) reduces scar contraction in cutaneous wound healing","volume":"14","author":"Cho","year":"2017","journal-title":"Tissue Eng. Regen. Med."},{"issue":"9","key":"10.1016\/j.bioactmat.2025.02.043_bib102","doi-asserted-by":"crossref","first-page":"14347","DOI":"10.1021\/acsnano.1c03252","article-title":"Separable microneedle patch to protect and deliver DNA nanovaccines against COVID-19","volume":"15","author":"Yin","year":"2021","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.bioactmat.2025.02.043_bib103","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1021\/acsnano.4c15130","article-title":"Inhalable siRNA targeting IL-11 nanoparticles significantly inhibit bleomycin-induced pulmonary fibrosis","volume":"19","author":"Dong","year":"2025","journal-title":"ACS Nano"},{"issue":"25","key":"10.1016\/j.bioactmat.2025.02.043_bib104","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn7162","article-title":"Inhaled siRNA nanoparticles targeting inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge","volume":"8","author":"Bai","year":"2022","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.bioactmat.2025.02.043_bib105","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1021\/jacs.8b01641","article-title":"Positively charged polyprodrug amphiphiles with enhanced drug loading and reactive oxygen species-responsive release ability for traceable synergistic therapy","volume":"140","author":"Li","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib106","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1002\/adma.201600554","article-title":"Traceable nanoparticle delivery of small interfering RNA and retinoic acid with temporally release ability to control neural stem cell differentiation for Alzheimer's disease therapy","volume":"28","author":"Zhang","year":"2016","journal-title":"Adv. Mater."},{"issue":"27","key":"10.1016\/j.bioactmat.2025.02.043_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1606","article-title":"Suprachoroidal gene transfer with nonviral nanoparticles","volume":"6","author":"Shen","year":"2020","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.bioactmat.2025.02.043_bib108","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1021\/acs.nanolett.8b00390","article-title":"Bioreducible polymeric nanoparticles containing multiplexed cancer stem cell regulating miRNAs inhibit glioblastoma growth and prolong survival","volume":"18","author":"Lopez-Bertoni","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay3255","article-title":"Carboxylated branched poly(\u03b2-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing","volume":"5","author":"Rui","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300897","article-title":"Blockage of osteopontin-integrin \u03b23 signaling in infrapatellar fat pad attenuates osteoarthritis in mice","volume":"10","author":"Dai","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib111","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2020.03.023","article-title":"Transdermal siRNA delivery by pH-switchable micelles with targeting effect suppress skin melanoma progression","volume":"322","author":"Wang","year":"2020","journal-title":"J. Contr. Release"},{"issue":"21","key":"10.1016\/j.bioactmat.2025.02.043_bib112","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1039\/D2CS00998F","article-title":"'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective","volume":"52","author":"Fu","year":"2023","journal-title":"Chem. Soc. Rev."},{"issue":"27","key":"10.1016\/j.bioactmat.2025.02.043_bib113","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"P. Natl. Acad. Sci. USA."},{"issue":"12","key":"10.1016\/j.bioactmat.2025.02.043_bib114","doi-asserted-by":"crossref","first-page":"12096","DOI":"10.1021\/acsnano.8b05292","article-title":"Cell-membrane immunotherapy based on natural killer cell membrane coated nanoparticles for the effective inhibition of primary and abscopal tumor growth","volume":"12","author":"Deng","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib115","first-page":"1","article-title":"Hydrogel-exosome system in tissue engineering: a promising therapeutic strategy","volume":"38","author":"Fan","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib116","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.2147\/IJN.S315040","article-title":"Antibacterial effect of honey-derived exosomes containing antimicrobial peptides against oral streptococci","volume":"16","author":"Leiva-Sabadini","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.02.043_bib117","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12010-018-2913-1","article-title":"In vitro wound healing activity of wheat-derived nanovesicles","volume":"188","author":"Sahin","year":"2019","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib118","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.2147\/IJN.S412717","article-title":"Advances in immunomodulatory mechanisms of mesenchymal stem cells-derived exosome on immune cells in scar formation","volume":"18","author":"Zhao","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"17","key":"10.1016\/j.bioactmat.2025.02.043_bib119","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2174\/0929867328666210902142015","article-title":"Engineered exosomes: a promising drug delivery strategy for brain diseases","volume":"29","author":"Jiang","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41565-023-01580-3","article-title":"Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity","volume":"19","author":"Liu","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib121","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1038\/s41467-023-40280-3","article-title":"Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment","volume":"14","author":"Zou","year":"2023","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.bioactmat.2025.02.043_bib122","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1021\/jacs.3c13123","article-title":"Programmable RNA loading of extracellular vesicles with toehold-release purification","volume":"146","author":"Malle","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-024-01673-7","article-title":"A large-scale machine learning analysis of inorganic nanoparticles in preclinical cancer research","author":"Mendes","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib124","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1039\/C9SC06497D","article-title":"Surface chemistry of gold nanoparticles for health-related applications","volume":"11","author":"Zhang","year":"2020","journal-title":"Chem. Sci."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.02.043_bib125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1039\/C3CC47634K","article-title":"Amphiphilic modification and asymmetric silica encapsulation of hydrophobic Au-FeO dumbbell nanoparticles","volume":"50","author":"Wu","year":"2014","journal-title":"Chem. Commun."},{"issue":"49","key":"10.1016\/j.bioactmat.2025.02.043_bib126","doi-asserted-by":"crossref","first-page":"19714","DOI":"10.1021\/ja209793b","article-title":"Near-infrared light-triggered dissociation of block copolymer micelles using upconverting nanoparticles","volume":"133","author":"Yan","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202105711","article-title":"Self-catalytic small Interfering RNA nanocarriers for synergistic treatment of neurodegenerative diseases","volume":"34","author":"Ji","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jddst.2017.11.013","article-title":"Chitosan-Mangafodipir nanoparticles designed for intranasal delivery of siRNA and DNA to brain","volume":"43","author":"Sanchez-Ramos","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib129","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1038\/s41467-021-23250-5","article-title":"Programmably tiling rigidified DNA brick on gold nanoparticle as multi-functional shell for cancer-targeted delivery of siRNAs","volume":"12","author":"Xue","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.02.043_bib130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1039\/C5BM00277J","article-title":"Utilising inorganic nanocarriers for gene delivery","volume":"4","author":"Loh","year":"2016","journal-title":"Biomater. Sci-Uk."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102388","article-title":"Cerium oxide nanoparticle delivery of microRNA-146a for local treatment of acute lung injury","volume":"34","author":"Niemiec","year":"2021","journal-title":"Nanomed-Nanotechnol"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib132","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12951-020-00759-3","article-title":"Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapy","volume":"19","author":"Yang","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121731","article-title":"Functional Au nanoparticles for engineering and long-term CT imaging tracking of mesenchymal stem cells in idiopathic pulmonary fibrosis treatment","volume":"288","author":"Bao","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131058","article-title":"Exposure to micron-grade silica particles triggers pulmonary fibrosis through cell-to-cell delivery of exosomal miR-107","volume":"266","author":"Xia","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"7082","key":"10.1016\/j.bioactmat.2025.02.043_bib135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nature04586","article-title":"Folding DNA to create nanoscale shapes and patterns","volume":"440","author":"Rothemund","year":"2006","journal-title":"Nature"},{"issue":"7245","key":"10.1016\/j.bioactmat.2025.02.043_bib136","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nature08016","article-title":"Self-assembly of DNA into nanoscale three-dimensional shapes","volume":"459","author":"Douglas","year":"2009","journal-title":"Nature"},{"issue":"5941","key":"10.1016\/j.bioactmat.2025.02.043_bib137","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1126\/science.1174251","article-title":"Folding DNA into twisted and curved nanoscale shapes","volume":"325","author":"Dietz","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106638","article-title":"Self-assembly of DNA origami for nanofabrication, biosensing, drug delivery, and computational storage","volume":"26","author":"He","year":"2023","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.bioactmat.2025.02.043_bib139","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/nl901165f","article-title":"Scaffolded DNA origami of a DNA tetrahedron molecular container","volume":"9","author":"Ke","year":"2009","journal-title":"Nano Lett."},{"issue":"6","key":"10.1016\/j.bioactmat.2025.02.043_bib140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nnano.2012.73","article-title":"Molecularly self-assembled nucleic acid nanoparticles for targeted siRNA delivery","volume":"7","author":"Lee","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.bioactmat.2025.02.043_bib141","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/anie.202009842","article-title":"A tubular DNA nanodevice as a siRNA\/chemo-drug co-delivery vehicle for combined cancer therapy","volume":"60","author":"Wang","year":"2021","journal-title":"Angew. Chem., Int. Ed."},{"issue":"20","key":"10.1016\/j.bioactmat.2025.02.043_bib142","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1021\/acs.nanolett.4c01222","article-title":"Nebulized inhalation of peptide-modified DNA origami to alleviate acute lung injury","volume":"24","author":"Wang","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib143","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2021.01.019","article-title":"Overcoming barriers by local drug delivery with liposomes","volume":"174","author":"Antimisiaris","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib144","article-title":"RNAi therapies: expanding applications for extrahepatic diseases and overcoming delivery challenges","volume":"201","author":"Lee","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.bioactmat.2025.02.043_bib145","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","article-title":"Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial","volume":"21","author":"Wu","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"22","key":"10.1016\/j.bioactmat.2025.02.043_bib146","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1021\/acs.nanolett.3c03547","article-title":"Inhalable gene therapy and the lung surfactant problem","volume":"23","author":"Kassab","year":"2023","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.02.043_bib166","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1186\/s12951-024-03065-4","article-title":"Gene editing tool-loaded biomimetic cationic vesicles with highly efficient bacterial internalization for in vivo eradication of pathogens","volume":"22","author":"Jia","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.bioactmat.2025.02.043_bib147","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41551-021-00794-x","article-title":"Lipid nanoparticles for the inhalation of mRNA","volume":"5","author":"Chang","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"17","key":"10.1016\/j.bioactmat.2025.02.043_bib148","doi-asserted-by":"crossref","first-page":"11335","DOI":"10.1021\/acsnano.4c00768","article-title":"Microfluidic platform enables shearless aerosolization of lipid nanoparticles for mRNA inhalation","volume":"18","author":"Kim","year":"2024","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.bioactmat.2025.02.043_bib149","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1177\/002013240204701203","article-title":"Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol","volume":"47","author":"Dhand","year":"2002","journal-title":"Respir. Care"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib150","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1038\/s41598-023-35872-4","article-title":"Low energy nebulization preserves integrity of SARS-CoV-2 mRNA vaccines for respiratory delivery","volume":"13","author":"van Rijn","year":"2023","journal-title":"Sci. Rep-Uk"},{"issue":"3","key":"10.1016\/j.bioactmat.2025.02.043_bib151","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/pharmaceutics13030385","article-title":"Nasal powder formulations: in-vitro characterisation of the impact of powders on nasal residence time and sensory effects","volume":"13","author":"Trenkel","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib152","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jconrel.2020.07.011","article-title":"Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery","volume":"326","author":"Shen","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib153","article-title":"Functional rescue of CFTR by aerosolized delivery of optimized CFTR mRNA using ReCode-LNPs in primary human bronchial epithelial cells derived from patients with cystic fibrosis","author":"Ishimaru","year":"2022","journal-title":"Am. J. Resp. Crit. Care"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib154","author":"Safety"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib155","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S1569-1993(24)00166-8","article-title":"03 inhaled LUNAR\u00ae-CFTR mRNA (ARCT-032) is safe and well-tolerated: a phase 1 study","volume":"23","author":"Geller","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib156","unstructured":"ReCode Therapeutics Doses First Patient in Phase 1 Clinical Study of Novel mRNA-based Therapy for the Treatment of Primary Ciliary Dyskinesia. <https:\/\/recodetx.com\/recode-therapeutics-doses-first-patient-in-phase-1-clinical-study-of-novel-mrna-based-therapy-for-the-treatment-of-primary-ciliary-dyskinesia\/>)."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib159","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.bioactmat.2025.02.043_bib160","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib161","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2021.11.023","article-title":"Pulmonary surfactant as a versatile biomaterial to fight COVID-19","volume":"342","author":"Herman","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib162","first-page":"406","article-title":"Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization","volume":"43","author":"Liao","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib163","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1038\/s41467-023-40185-1","article-title":"Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage","volume":"14","author":"Beck","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bioactmat.2025.02.043_bib164","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s12276-023-01017-w","article-title":"Mesenchymal stromal cells facilitate resolution of pulmonary fibrosis by miR-29c and miR-129 intercellular transfer","volume":"55","author":"Nataliya","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib165","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.biotechadv.2018.02.016","article-title":"Bacterial components as naturally inspired nano-carriers for drug\/gene delivery and immunization: set the bugs to work?","volume":"36","author":"Farjadian","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib167","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1038\/s41467-024-51056-8","article-title":"Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy","volume":"15","author":"Bai","year":"2024","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bioactmat.2025.02.043_bib168","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.02.043_bib169","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11095-022-03433-5","article-title":"CNS delivery of nucleic acid therapeutics: beyond the blood-brain barrier and towards specific cellular targeting","volume":"40","author":"D'Souza","year":"2023","journal-title":"Pharm. Res-Dordr."},{"issue":"12","key":"10.1016\/j.bioactmat.2025.02.043_bib170","first-page":"1043","article-title":"ASO drug Qalsody (tofersen) targets amyotrophic lateral sclerosis, Trends Pharmacol","volume":"44","author":"Jin","year":"2023","journal-title":"Sci."},{"issue":"23","key":"10.1016\/j.bioactmat.2025.02.043_bib171","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMc2300400","article-title":"Tominersen in adults with manifest huntington's disease","volume":"389","author":"McColgan","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib172","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","article-title":"In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer's disease","volume":"22","author":"Park","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib173","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jconrel.2019.08.024","article-title":"Poly(\u03b2-amino ester)-based gene delivery systems: from discovery to therapeutic applications","volume":"310","author":"Cordeiro","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib174","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2017.07.009","article-title":"Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors","volume":"262","author":"Mastorakos","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12974-022-02578-9","article-title":"Human PMSCs-derived small extracellular vesicles alleviate neuropathic pain through miR-26a-5p\/Wnt5a in SNI mice model","volume":"19","author":"Lu","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.bioactmat.2025.02.043_bib176","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/mt.2016.126","article-title":"Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing","volume":"24","author":"Didiot","year":"2016","journal-title":"Mol. Ther."},{"issue":"33","key":"10.1016\/j.bioactmat.2025.02.043_bib177","doi-asserted-by":"crossref","first-page":"14166","DOI":"10.1039\/D0NR07516G","article-title":"Hypoxia-specific anti-RAGE exosomes for nose-to-brain delivery of anti-miR-181a oligonucleotide in an ischemic stroke model","volume":"13","author":"Kim","year":"2021","journal-title":"Nanoscale"},{"issue":"2","key":"10.1016\/j.bioactmat.2025.02.043_bib178","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1021\/nn506248s","article-title":"Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles","volume":"9","author":"Cohen","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib179","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11095-018-2503-5","article-title":"Nasal administration of cationic nanoemulsions as nucleic acids delivery systems aiming at mucopolysaccharidosis type I gene therapy","volume":"35","author":"Schuh","year":"2018","journal-title":"Pharm. Res-Dordr."},{"issue":"24","key":"10.1016\/j.bioactmat.2025.02.043_bib180","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/acs.biochem.3c00371","article-title":"Lipid nanoparticles deliver mRNA to the brain after an intracerebral injection","volume":"62","author":"Tuma","year":"2023","journal-title":"Biochemistry-Us"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib181","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biomaterials.2019.04.020","article-title":"Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo","volume":"209","author":"Kozielski","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib182","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biomaterials.2016.05.025","article-title":"Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival","volume":"100","author":"Mangraviti","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib183","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2016.02.032","article-title":"Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration","volume":"227","author":"Van Woensel","year":"2016","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.bioactmat.2025.02.043_bib184","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.bioactmat.2025.02.043_bib185","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/17425247.2018.1496080","article-title":"Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye","volume":"15","author":"Wang","year":"2018","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib187","article-title":"Strategies for non-viral vectors targeting organs beyond the liver","author":"Kim","year":"2023","journal-title":"Nat. Nanotechnol."},{"issue":"8","key":"10.1016\/j.bioactmat.2025.02.043_bib188","first-page":"2159","article-title":"Light-responsive biomaterials for ocular drug delivery, Drug Deliv","volume":"13","author":"Abdelmohsen","year":"2022","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.02.043_bib190","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2177088","article-title":"CRISPR\/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients","volume":"12","author":"Tian","year":"2023","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib191","article-title":"Antisense oligonucleotides selectively enter human-derived antibiotic-resistant bacteria through bacterial-specific ATP-binding cassette sugar transporter","volume":"35","author":"Liu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib192","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201902776","article-title":"Anti-VEGF-aptamer modified C-dots-a hybrid nanocomposite for topical treatment of ocular vascular disorders","volume":"15","author":"Shoval","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib193","article-title":"Circulating small extracellular vesicles involved in systemic regulation respond to RGC degeneration in glaucoma","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib194","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1039\/D4TB00849A","article-title":"Cationic-motif-modified exosomes for mRNA delivery to retinal photoreceptors","volume":"12","author":"Cotto","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib195","article-title":"Corneal neovascularization is inhibited with nucleolin-binding aptamer","volume":"193","author":"Vivanco-Rojas","year":"2020","journal-title":"AS1411, Exp. Eye Res."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib196","article-title":"An mRNA-encoded dominant-negative inhibitor of transcription factor RUNX1 suppresses vitreoretinal disease in experimental models","volume":"16","author":"O'Hare","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.02.043_bib197","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40824-021-00226-6","article-title":"Recent advances in transdermal drug delivery systems: a review","volume":"25","author":"Jeong","year":"2021","journal-title":"Biomater. Res."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib198","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jconrel.2015.09.017","article-title":"Nucleic acid delivery into skin for the treatment of skin disease: proofs-of-concept, potential impact, and remaining challenges","volume":"219","author":"Zakrewsky","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib208","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jconrel.2024.05.048","article-title":"ROS-scavenging lipid-based liquid crystalline as a favorable stem cell extracellular vesicles delivery vector to promote wound healing","volume":"371","author":"Li","year":"2024","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.bioactmat.2025.02.043_bib199","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41565-021-00910-7","article-title":"Bioorthogonal catalytic patch","volume":"16","author":"Chen","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"25","key":"10.1016\/j.bioactmat.2025.02.043_bib200","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh2213","article-title":"Blue-ringed octopus-inspired microneedle patch for robust tissue surface adhesion and active injection drug delivery","volume":"9","author":"Zhu","year":"2023","journal-title":"Sci. Adv."},{"issue":"23","key":"10.1016\/j.bioactmat.2025.02.043_bib201","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300339","article-title":"Microneedle-mediated transcutaneous immunization: potential in nucleic acid vaccination","volume":"12","author":"Wang","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124435","article-title":"Breaking barriers: innovative approaches for skin delivery of RNA therapeutics","volume":"661","author":"Subramanian","year":"2024","journal-title":"Int. J. Pharmaceut."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.02.043_bib203","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/mt.2009.273","article-title":"First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder","volume":"18","author":"Leachman","year":"2010","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.bioactmat.2025.02.043_bib204","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/molecules21101279","article-title":"Development of an innovative intradermal siRNA delivery system using a combination of a functional stearylated cytoplasm-responsive peptide and a tight junction-opening peptide","volume":"21","author":"Ibaraki","year":"2016","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bioactmat.2025.02.043_bib205","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1039\/D1NR06353G","article-title":"Transdermal delivery of poly-hyaluronic acid-based spherical nucleic acids for chemogene therapy","volume":"14","author":"Jiang","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib206","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1038\/s41467-023-42714-4","article-title":"Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib207","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2018.03.026","article-title":"Transdermal anti-nuclear kappaB siRNA therapy for atopic dermatitis using a combination of two kinds of functional oligopeptide","volume":"542","author":"Ibaraki","year":"2018","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib209","article-title":"Overcoming thickened pathological skin in psoriasis via iontophoresis combined with tight junction-opening peptide AT1002 for intradermal delivery of NF-\u03baB decoy oligodeoxynucleotide","volume":"602","author":"Fukuta","year":"2021","journal-title":"Int. J. Pharm. (Amst.)"},{"issue":"32","key":"10.1016\/j.bioactmat.2025.02.043_bib210","doi-asserted-by":"crossref","first-page":"16724","DOI":"10.1039\/D0NR02759F","article-title":"Biodegradable microneedle patch for transdermal gene delivery","volume":"12","author":"Qu","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib211","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2020.04.038","article-title":"Topical delivery of siRNA into skin using ionic liquids","volume":"323","author":"Dharamdasani","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib212","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb6049","article-title":"Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations","volume":"6","author":"Mandal","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib213","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae883","article-title":"Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity","author":"You","year":"2025","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.02.043_bib214","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1248\/bpb.b22-00746","article-title":"Use of iontophoresis technology for transdermal delivery of a minimal mRNA vaccine as a potential melanoma therapeutic","volume":"46","author":"Husseini","year":"2023","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib215","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.982008","article-title":"miR-17-92 cluster in osteoarthritis: regulatory roles and clinical utility","volume":"13","author":"Pan","year":"2022","journal-title":"Front. Genet."},{"issue":"38","key":"10.1016\/j.bioactmat.2025.02.043_bib229","doi-asserted-by":"crossref","first-page":"50484","DOI":"10.1021\/acsami.4c12159","article-title":"Aptamer-modified tetrahedral framework nucleic acid synergized with TGF-\u03b23 to promote cartilage protection in osteoarthritis by enhancing chondrogenic differentiation of MSCs","volume":"16","author":"Shi","year":"2024","journal-title":"Acs Appl. Mater. Inter."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib216","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coph.2018.03.013","article-title":"Intra-articular drug delivery systems for joint diseases","volume":"40","author":"Rai","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20417314241265897","article-title":"Mechanisms of hydrogel-based microRNA delivery systems and its application strategies in targeting inflammatory diseases","volume":"15","author":"Hu","year":"2024","journal-title":"J. Tissue Eng."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib218","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300877","article-title":"Bivalent gadolinium ions forming injectable hydrogels for simultaneous in situ vaccination therapy and imaging of soft tissue sarcoma","volume":"12","author":"Wang","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib219","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000294","article-title":"Imaging of injectable hydrogels delivered into myocardium with SPECT\/CT","volume":"9","author":"Uman","year":"2020","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib220","first-page":"S121","article-title":"Functional improvements in knee kinematics during walking gait over six months following treatment with Xt-150: pooled results from two clinical trials, Osteoarthr","volume":"31","author":"Thewlis","year":"2023","journal-title":"Cartilage"},{"issue":"9","key":"10.1016\/j.bioactmat.2025.02.043_bib221","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1021\/acsbiomaterials.0c00960","article-title":"Articular cartilage- and synoviocyte-binding poly(ethylene glycol) nanocomposite microgels as intra-articular drug delivery vehicles for the treatment of osteoarthritis","volume":"6","author":"Castro","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib222","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-023-02086-9","article-title":"Engineering exosomes derived from subcutaneous fat MSCs specially promote cartilage repair as miR-199a-3p delivery vehicles in Osteoarthritis","volume":"21","author":"Zhao","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib223","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jconrel.2024.04.009","article-title":"Surface functionalization of exosomes for chondrocyte-targeted siRNA delivery and cartilage regeneration","volume":"369","author":"Zhang","year":"2024","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.bioactmat.2025.02.043_bib224","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmat2116","article-title":"Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage","volume":"7","author":"Rothenfluh","year":"2008","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib225","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41551-021-00780-3","article-title":"Amelioration of post-traumatic osteoarthritis via nanoparticle depots delivering small interfering RNA to damaged cartilage","volume":"5","author":"Bedingfield","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib226","article-title":"Engineered MSC\u2010sEVs as a versatile nanoplatform for enhanced osteoarthritis treatment via targeted elimination of senescent chondrocytes and maintenance of cartilage matrix metabolic homeostasis","author":"Feng","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib227","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abk0011","article-title":"Stem cell-homing hydrogel-based miR-29b-5p delivery promotes cartilage regeneration by suppressing senescence in an osteoarthritis rat model","volume":"8","author":"Zhu","year":"2022","journal-title":"Sci. Adv."},{"issue":"41","key":"10.1016\/j.bioactmat.2025.02.043_bib228","doi-asserted-by":"crossref","first-page":"E6199","DOI":"10.1073\/pnas.1608245113","article-title":"Suppression of NF-\u03baB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury","volume":"113","author":"Yan","year":"2016","journal-title":"P. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib230","article-title":"Tetrahedral framework nucleic acid loaded miR-23b inhibits synovial inflammation and cartilage matrix degradation in the treatment of rheumatoid arthritis","volume":"34","author":"Wang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib231","first-page":"S41","article-title":"Efficacy of XT-150, a novel non-viral gene therapy delivering il-10v, on moderate to severe pain due to knee osteoarthritis: patient subgroup analysis, Osteoarthr","volume":"32","author":"Rutman","year":"2024","journal-title":"Cartilage"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib232","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.omtn.2022.12.008","article-title":"Chemically modified small interfering RNA targeting Hedgehog signaling pathway for rheumatoid arthritis therapy","volume":"31","author":"Lin","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"2","key":"10.1016\/j.bioactmat.2025.02.043_bib233","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00441-016-2563-y","article-title":"Effect of inhibiting MMP13 and ADAMTS5 by intra-articular injection of small interfering RNA in a surgically induced osteoarthritis model of mice","volume":"368","author":"Hoshi","year":"2017","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib234","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12951-025-03103-9","article-title":"Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence","volume":"23","author":"Kong","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"12","key":"10.1016\/j.bioactmat.2025.02.043_bib235","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/art.41794","article-title":"Amelioration of posttraumatic osteoarthritis in mice using intraarticular silencing of periostin via nanoparticle-based small interfering RNA","volume":"73","author":"Duan","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib236","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12951-024-03046-7","article-title":"A ROS-responsive hydrogel encapsulated with matrix metalloproteinase-13 siRNA nanocarriers to attenuate osteoarthritis progression","volume":"23","author":"Wang","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib237","article-title":"Nanoengineered cargo with targeted in vivo Foxo3 gene editing modulated mitophagy of chondrocytes to alleviate osteoarthritis","author":"Chen","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib238","first-page":"634","article-title":"A novel mesenchymal stem cell-targeting dual-miRNA delivery system based on aptamer-functionalized tetrahedral framework nucleic acids: application to endogenous regeneration of articular cartilage","volume":"40","author":"Fu","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib239","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1026061507004","article-title":"Molecular mechanisms in endothelial regulation of cardiac function","volume":"253","author":"Kuruvilla","year":"2003","journal-title":"Mol. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.bioactmat.2025.02.043_bib240","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1582-4934.2010.01133.x","article-title":"Telocytes in endocardium: electron microscope evidence","volume":"14","author":"Gherghiceanu","year":"2010","journal-title":"J. Cell Mol. Med."},{"issue":"30","key":"10.1016\/j.bioactmat.2025.02.043_bib257","first-page":"19470","article-title":"Nanoparticle-patch system for localized, effective, and sustained miRNA administration into infarcted myocardium to alleviate myocardial ischemia-reperfusion injury","volume":"18","author":"Chen","year":"2024","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.bioactmat.2025.02.043_bib241","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12265-012-9378-3","article-title":"Cell delivery routes for stem cell therapy to the heart: current and future approaches","volume":"5","author":"Campbell","year":"2012","journal-title":"J. Cardiovasc. Transl."},{"issue":"5","key":"10.1016\/j.bioactmat.2025.02.043_bib242","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.yjmcc.2010.09.003","article-title":"Current strategies for myocardial gene delivery","volume":"50","author":"Katz","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.02.043_bib243","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12350-011-9369-9","article-title":"Myocardial substrate and route of administration determine acute cardiac retention and lung bio-distribution of cardiosphere-derived cells","volume":"18","author":"Bonios","year":"2011","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib244","first-page":"5","article-title":"Comparison of intracoronary versus intravenous administration of adenosine for measurement of coronary fractional flow reserve, Circ","volume":"8","author":"Schlundt","year":"2015","journal-title":"Cardiovasc. Interv."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib245","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1021\/acsnano.3c08346","article-title":"A self-homing and traceable cardiac patch leveraging ferumoxytol for spatiotemporal therapeutic delivery","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib246","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/s41467-024-50312-1","article-title":"Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice","volume":"15","author":"Weng","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bioactmat.2025.02.043_bib247","first-page":"899","article-title":"High\u2010dose plasmid\u2010mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis\u2010I). A phase I, open\u2010label, two\u2010year follow\u2010up trial","volume":"82","author":"Favaloro","year":"2013","journal-title":"Catheter. Cardio. Inte."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib248","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41573-021-00355-6","article-title":"VEGFA mRNA for regenerative treatment of heart failure","volume":"21","author":"Collen","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib251","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.omtm.2018.04.003","article-title":"Biocompatible, purified VEGF-A mRNA improves cardiac function after intracardiac injection 1 week post-myocardial infarction in swine","volume":"9","author":"Carlsson","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"10","key":"10.1016\/j.bioactmat.2025.02.043_bib252","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nbt.2682","article-title":"Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction","volume":"31","author":"Zangi","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib253","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jconrel.2024.04.018","article-title":"Cardiac delivery of modified mRNA using lipid nanoparticles: cellular targets and biodistribution after intramyocardial administration","volume":"369","author":"Labonia","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib254","article-title":"Injectable hydrogel with MSNs\/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.02.043_bib255","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7150\/thno.47021","article-title":"Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted silencing to improve angiogenesis following myocardial infarction","volume":"11","author":"Liao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2025.02.043_bib256","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40824-023-00410-w","article-title":"Exosomes derived from mir-214-3p overexpressing mesenchymal stem cells promote myocardial repair","volume":"27","author":"Zhu","year":"2023","journal-title":"Biomater. Res."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib258","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2016.10.017","article-title":"Simultaneous regulation of apoptotic gene silencing and angiogenic gene expression for myocardial infarction therapy: single-carrier delivery of SHP-1 siRNA and VEGF-expressing pDNA","volume":"243","author":"Kim","year":"2016","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.bioactmat.2025.02.043_bib259","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"52","key":"10.1016\/j.bioactmat.2025.02.043_bib260","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"P. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib261","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-024-01680-8","article-title":"Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells","author":"Lian","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2025.02.043_bib262","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-022-01031-w","article-title":"Spatial control of robust transgene expression in mouse artery endothelium under ultrasound guidance","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Tar."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X25000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X25000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:10:26Z","timestamp":1778890226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X25000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":256,"alternative-id":["S2452199X25000994"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2025.02.043","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in locally administered nucleic acid therapeutics","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2025.02.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}